TELLES advised the PharmaLex group, a global leading specialized service provider for the pharma, biotech and medtech industries, on the integration process of the Portuguese pharmaceutical and biotech consultancy company, PharSolution, in the PharmaLex group.
TELLES’ Corporate, Commercial and M&A team, involved in this operation, advised all process stages including carry out due diligence on Pharsolution and its subsidiaries, negotiate all legal and contractual instruments underlying the transaction and its implementation.
This operation was led by , partner from TELLES Corporate, Commenrcial and M&A practice, with the active involvement of , senior associate, and , associate, in the same practice.
As stated by Francisco Espregueira Mendes "it was a challenging operation, due to the complexity of the various issues underlying the operation, but equally rewarding, due to the level of technical and legal sophistication of the parties and respective consultants involved and the degree of involvement of these two key players who provide specialised services in the pharmaceutical industry".
With the closing of this process, the PharmaLex group enters the Portuguese market and reinforcing its global approach while providing local support.
This operation enable PharmaLex to expand its portfolio of technology-enabled service solutions, enhance its existing pharmacovigilance databases globally and deliver local affiliate support in Portugal for all its solutions in the areas of regulatory, pharmacovigilance, risk management, quality and manufacturing, strategic advice and scientific affairs.
The Pharmalex Group, with headquarters in Germany, had a turnover of approximately 200 million dollars in 2021 and integrates a workforce of approximately 2000 employees, having 47 offices in 25 countries worldwide, including since very recently Portugal.